Detection of carbapenemases and other mechanisms of enzymatic resistance to β-lactams in Enterobacteriaceae with diminished susceptibility to carbapenems in a tertiary care hospital

Nordmann, 2011, Global spread of carbapenemase producing Enterobacteriaceae, Emerg Infect Dis, 17, 1791, 10.3201/eid1710.110655 Oteo, 2013, Carbapenemase-producing Enterobacteriaceae in Spain in 2012, Antimicrob Agents Chemother, 57, 6344, 10.1128/AAC.01513-13 Hrabák, 2014, Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories, Clin Microbiol Infect, 20, 839, 10.1111/1469-0691.12678 Wozniak, 2012, Porin alterations present in non-carbapenemaseproducing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile, J Med Microbiol, 61, 1270, 10.1099/jmm.0.045799-0 Tsakris, 2010, A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates, J Antimicrob Chemother, 65, 1664, 10.1093/jac/dkq210 Maurer, 2015, Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm, J Clin Microbiol, 53, 95, 10.1128/JCM.01692-14 CLSI, 2015 Coudron, 2005, Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli and Proteus mirabilis, J Clin Microbiol, 43, 4163, 10.1128/JCM.43.8.4163-4167.2005 Poirel, 2011, Multiplex PCR for detection of acquired carbapenemase genes, Diagn Microbiol Infect Dis, 70, 119, 10.1016/j.diagmicrobio.2010.12.002 Monstein, 2007, Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae, APMIS, 115, 1400, 10.1111/j.1600-0463.2007.00722.x Pèc)rez-Pèc)rez, 2002, Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR, J Clin Microbiol, 40, 2153, 10.1128/JCM.40.6.2153-2162.2002 Livermore, 1995, Beta-lactamases in laboratory and clinical resistance, Clin Microbiol Rev, 8, 557, 10.1128/CMR.8.4.557 Martínez-Martínez, 1999, Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae, Antimicrob Agents Chemother, 43, 1669, 10.1128/AAC.43.7.1669 Livermore, 2008, Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001•06, J Antimicrob Chemother, 62, 41 Papaparaskevas, 2007, Differences in the evolution of imipenem susceptibility among Klebsiella pneumoniae and Escherichia coli isolates during a 6-year period in a tertiary care hospital, Int J Antimicrob Agents, 29, 197, 10.1016/j.ijantimicag.2006.09.010 Lastra De, 2014, Detection of serinocarbapenemases Class A and other mechanisms of enzymatic resistance to β-lactams in enterobacteria strains with diminished susceptibility to carbapenems isolated of patients in a university hospital, Rev Chil Infectol, 31, 682 Cantón, 2008, Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe, Clin Microbiol Infect, 14, 144, 10.1111/j.1469-0691.2007.01850.x Seral, 2012, Emergencia de β-lactamasas AmpC plasmídicas (pAmpC ó cefamicinasas): origen, importancia, detección y alternativas terapèc)uticas, Rev Esp Quim, 25, 89 Fernández-Cuenca, 2006, In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40kDa outer membrane protein and hyperproduction of AmpC β-lactamase, Int J Antimicrob Agents, 27, 549, 10.1016/j.ijantimicag.2006.01.005